Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
FATE

Fate Therapeutics

$17.95

0.49 (2.81%)

05:06
09/16/19
09/16
05:06
09/16/19
05:06
Recommendations
Fate Therapeutics analyst commentary at Piper Jaffray »

Fate Therapeutics target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
FATE

Fate Therapeutics

$17.72

-1.37 (-7.18%)

05:54
09/12/19
09/12
05:54
09/12/19
05:54
Syndicate
Fate Therapeutics 8.6M share Spot Secondary priced at $17.50 »

Jefferies acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

EPM

Evolution Petroleum

$6.53

0.38 (6.18%)

, EYPT

EyePoint

$1.63

0.06 (3.82%)

19:03
09/11/19
09/11
19:03
09/11/19
19:03
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

EPM

Evolution Petroleum

$6.53

0.38 (6.18%)

EYPT

EyePoint

$1.63

0.06 (3.82%)

YELP

Yelp

$35.55

1.55 (4.56%)

GRPN

Groupon

$2.89

-0.09 (-3.02%)

TLRD

Tailored Brands

$5.33

-1.34 (-20.09%)

ACB

Aurora Cannabis

$5.84

-0.53 (-8.32%)

OXM

Oxford Industries

$72.59

-5.93 (-7.55%)

ORCL

Oracle

$55.81

0.34 (0.61%)

CELH

Celsius Holdings

$4.20

0.32 (8.25%)

CPRX

Catalyst Pharmaceuticals

$6.65

-0.39 (-5.54%)

DXC

DXC Technology

$34.00

-2.11 (-5.84%)

LSTR

Landstar System

$117.62

1.94 (1.68%)

APLS

Apellis

$30.21

-0.87 (-2.80%)

FATE

Fate Therapeutics

$17.71

-1.38 (-7.23%)

AMRX

Amneal Pharmaceuticals

$3.43

-0.16 (-4.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 11

    Sep

  • 11

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

  • 19

    Sep

  • 19

    Sep

  • 23

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 24

    Oct

  • 06

    Nov

  • 13

    Nov

  • 12

    Sep

  • 13

    Sep

FATE

Fate Therapeutics

$18.36

-0.73 (-3.82%)

16:08
09/11/19
09/11
16:08
09/11/19
16:08
Syndicate
Fate Therapeutics $150M Spot Secondary re-offered at $17.50 »

Jefferies is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FATE

Fate Therapeutics

$18.37

-0.72 (-3.77%)

16:02
09/11/19
09/11
16:02
09/11/19
16:02
Syndicate
Fate Therapeutics files to sell common stock, no amount given »

Jefferies and Citigroup…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FATE

Fate Therapeutics

$16.33

-0.83 (-4.84%)

08:11
09/03/19
09/03
08:11
09/03/19
08:11
Hot Stocks
Fate Therapeutics announces FDA clearance of IND application for FT596 »

Fate Therapeutic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

Over a month ago
FATE

Fate Therapeutics

$18.26

0.3 (1.67%)

08:14
08/14/19
08/14
08:14
08/14/19
08:14
Hot Stocks
Fate Therapeutics announces issuance of foundational patent for CAR T cells »

Fate Therapeutics, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

FATE

Fate Therapeutics

$19.24

0.71 (3.83%)

07:49
08/09/19
08/09
07:49
08/09/19
07:49
Initiation
Fate Therapeutics initiated at BTIG »

Fate Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

FATE

Fate Therapeutics

$19.24

0.71 (3.83%)

07:32
08/09/19
08/09
07:32
08/09/19
07:32
Initiation
Fate Therapeutics initiated at BTIG »

Fate Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

FATE

Fate Therapeutics

$19.85

0.55 (2.85%)

07:30
08/07/19
08/07
07:30
08/07/19
07:30
Recommendations
Fate Therapeutics analyst commentary at Wedbush »

Fate Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.